These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9250500

  • 1. [Treatment of prostate cancer by radiotherapy].
    Akino H, Ohyama N, Mori H, Kanamaru H, Okada K, Yoshida M, Ishii Y, Arai Y.
    Hinyokika Kiyo; 1997 Jun; 43(6):461-4. PubMed ID: 9250500
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of localized prostate cancer: radical prostatectomy versus radiation therapy].
    Kanamaru H, Akino H, Mori H, Okada K, Arai Y.
    Hinyokika Kiyo; 1996 Oct; 42(10):817-20. PubMed ID: 8951481
    [Abstract] [Full Text] [Related]

  • 3. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
    Akakura K, Suzuki H, Ichikawa T, Fujimoto H, Maeda O, Usami M, Hirano D, Takimoto Y, Kamoto T, Ogawa O, Sumiyoshi Y, Shimazaki J, Kakizoe T, Japanese Study Group for Locally Advanced Prostate Cancer.
    Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF, Cozzarini C, Briganti A, Suardi N, Salonia A, Bertini R, Gallina A, Bianchi M, Fantini GV, Bolognesi A, Fazio F, Montorsi F, Rigatti P.
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [Abstract] [Full Text] [Related]

  • 5. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
    Bhatta-Dhar N, Reuther AM, Zippe C, Klein EA.
    Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
    [Abstract] [Full Text] [Related]

  • 6. Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation.
    Vargas CE, Galalae R, Demanes J, Harsolia A, Meldolesi E, Nürnberg N, Schour L, Martinez A.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1474-82. PubMed ID: 15964706
    [Abstract] [Full Text] [Related]

  • 7. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
    Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA.
    J Urol; 2007 Jun 01; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
    [Abstract] [Full Text] [Related]

  • 8. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D, Loewen H, Roggenbuck U, Musch M, Klevecka V.
    BJU Int; 2006 May 01; 97(5):985-91. PubMed ID: 16643480
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
    Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML.
    J Urol; 2007 Sep 01; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
    [Abstract] [Full Text] [Related]

  • 10. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC.
    J Natl Cancer Inst; 2004 Sep 15; 96(18):1358-67. PubMed ID: 15367568
    [Abstract] [Full Text] [Related]

  • 11. Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer.
    Miyake H, Sakai I, Harada K, Hara I, Eto H.
    Int J Urol; 2004 Jun 15; 11(6):397-401. PubMed ID: 15157209
    [Abstract] [Full Text] [Related]

  • 12. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy).
    Tewari A, Raman JD, Chang P, Rao S, Divine G, Menon M.
    Urology; 2006 Dec 15; 68(6):1268-74. PubMed ID: 17169648
    [Abstract] [Full Text] [Related]

  • 13. [Locally advanced prostate cancer: definition, prognosis and treatment].
    Plantade A, Massard C, de Crevoisier R, Fizazi K.
    Bull Cancer; 2007 Jul 15; 94(7 Suppl):F50-61. PubMed ID: 17845994
    [Abstract] [Full Text] [Related]

  • 14. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes?
    King CR, Presti JC, Gill H, Brooks J, Hancock SL.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):341-7. PubMed ID: 15145146
    [Abstract] [Full Text] [Related]

  • 15. Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients.
    Cozzarini C, Bolognesi A, Ceresoli GL, Fiorino C, Rossa A, Bertini R, Colombo R, Da Pozzo L, Montorsi F, Roscigno M, Calandrino R, Rigatti P, Villa E.
    Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):674-83. PubMed ID: 15183470
    [Abstract] [Full Text] [Related]

  • 16. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era.
    D'Amico AV, Whittington R, Malkowicz SB, Cote K, Loffredo M, Schultz D, Chen MH, Tomaszewski JE, Renshaw AA, Wein A, Richie JP.
    Cancer; 2002 Jul 15; 95(2):281-6. PubMed ID: 12124827
    [Abstract] [Full Text] [Related]

  • 17. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A, Varga Z, Von Knobloch R.
    J Urol; 2002 Apr 15; 167(4):1681-6. PubMed ID: 11912387
    [Abstract] [Full Text] [Related]

  • 18. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients.
    Cozzarini C, Montorsi F, Fiorino C, Alongi F, Bolognesi A, Da Pozzo LF, Guazzoni G, Freschi M, Roscigno M, Scattoni V, Rigatti P, Di Muzio N.
    Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):966-74. PubMed ID: 19619960
    [Abstract] [Full Text] [Related]

  • 19. Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy--a propensity scoring approach.
    Tewari A, Divine G, Chang P, Shemtov MM, Milowsky M, Nanus D, Menon M.
    J Urol; 2007 Mar 15; 177(3):911-5. PubMed ID: 17296374
    [Abstract] [Full Text] [Related]

  • 20. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A, Ohlmann CH.
    Aktuelle Urol; 2005 Jun 15; 36(3):219-29. PubMed ID: 16001337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.